Literature DB >> 18986664

The RNA stability regulator HuR regulates L1 protein expression in vivo in differentiating cervical epithelial cells.

S A Cumming1, T Chuen-Im, J Zhang, S V Graham.   

Abstract

Human papillomavirus (HPV) L1 and L2 capsid protein expression is restricted to the granular layer of infected, stratified epithelia and is regulated at least partly at post-transcriptional levels. For HPV16, a 79 nt late regulatory element (LRE) is involved in this control. Using W12 cells as a model for HPV16-infected differentiating cervical epithelial cells we show that HuR, a key cellular protein that controls mRNA stability, binds the LRE most efficiently in nuclear and cytoplasmic extracts of differentiated cells. Further, HuR binds the 3' U-rich portion of the LRE directly in vitro. Overexpression of HuR in undifferentiated W12 cells results in an increase in L1 mRNA and protein levels while siRNA knock-down of HuR in differentiated W12 cells depletes L1 expression. In differentiated cervical epithelial cells HuR may bind and stabilise L1 mRNAs aiding translation of L1 protein.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18986664      PMCID: PMC2789472          DOI: 10.1016/j.virol.2008.10.003

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  40 in total

1.  Specific inactivation of inhibitory sequences in the 5' end of the human papillomavirus type 16 L1 open reading frame results in production of high levels of L1 protein in human epithelial cells.

Authors:  Brian Collier; Daniel Oberg; Xiaomin Zhao; Stefan Schwartz
Journal:  J Virol       Date:  2002-03       Impact factor: 5.103

2.  A negative regulatory element in the human papillomavirus type 16 genome acts at the level of late mRNA stability.

Authors:  I M Kennedy; J K Haddow; J B Clements
Journal:  J Virol       Date:  1991-04       Impact factor: 5.103

3.  RNA stabilization by the AU-rich element binding protein, HuR, an ELAV protein.

Authors:  S S Peng; C Y Chen; N Xu; A B Shyu
Journal:  EMBO J       Date:  1998-06-15       Impact factor: 11.598

4.  The inhibitory activity of the AU-rich RNA element in the human papillomavirus type 1 late 3' untranslated region correlates with its affinity for the elav-like HuR protein.

Authors:  M Sokolowski; H Furneaux; S Schwartz
Journal:  J Virol       Date:  1999-02       Impact factor: 5.103

5.  Properties of a non-tumorigenic human cervical keratinocyte cell line.

Authors:  M A Stanley; H M Browne; M Appleby; A C Minson
Journal:  Int J Cancer       Date:  1989-04-15       Impact factor: 7.396

6.  The human papillomavirus type 16 negative regulatory RNA element interacts with three proteins that act at different posttranscriptional levels.

Authors:  M D Koffa; S V Graham; Y Takagaki; J L Manley; J B Clements
Journal:  Proc Natl Acad Sci U S A       Date:  2000-04-25       Impact factor: 11.205

7.  Differentiation-linked human papillomavirus types 6 and 11 transcription in genital condylomata revealed by in situ hybridization with message-specific RNA probes.

Authors:  M H Stoler; S M Wolinsky; A Whitbeck; T R Broker; L T Chow
Journal:  Virology       Date:  1989-09       Impact factor: 3.616

8.  A cellular 65-kDa protein recognizes the negative regulatory element of human papillomavirus late mRNA.

Authors:  W Dietrich-Goetz; I M Kennedy; B Levins; M A Stanley; J B Clements
Journal:  Proc Natl Acad Sci U S A       Date:  1997-01-07       Impact factor: 11.205

9.  Integration of human papillomavirus type 16 into the human genome correlates with a selective growth advantage of cells.

Authors:  S Jeon; B L Allen-Hoffmann; P F Lambert
Journal:  J Virol       Date:  1995-05       Impact factor: 5.103

10.  Analysis of novel human papillomavirus type 16 late mRNAs in differentiated W12 cervical epithelial cells.

Authors:  Steven G Milligan; Thanaporn Veerapraditsin; Boolang Ahamet; Sarah Mole; Sheila V Graham
Journal:  Virology       Date:  2006-11-13       Impact factor: 3.616

View more
  11 in total

Review 1.  Regulation of human papillomavirus gene expression by splicing and polyadenylation.

Authors:  Cecilia Johansson; Stefan Schwartz
Journal:  Nat Rev Microbiol       Date:  2013-03-11       Impact factor: 60.633

Review 2.  Human papillomavirus: gene expression, regulation and prospects for novel diagnostic methods and antiviral therapies.

Authors:  Sheila V Graham
Journal:  Future Microbiol       Date:  2010-10       Impact factor: 3.165

Review 3.  Strategies for viral RNA stability: live long and prosper.

Authors:  Alexa M Dickson; Jeffrey Wilusz
Journal:  Trends Genet       Date:  2011-07       Impact factor: 11.639

Review 4.  RNA Binding Proteins that Control Human Papillomavirus Gene Expression.

Authors:  Naoko Kajitani; Stefan Schwartz
Journal:  Biomolecules       Date:  2015-05-05

Review 5.  Splicing and Polyadenylation of Human Papillomavirus Type 16 mRNAs.

Authors:  Chengjun Wu; Naoko Kajitani; Stefan Schwartz
Journal:  Int J Mol Sci       Date:  2017-02-09       Impact factor: 5.923

Review 6.  Multiple functions of the RNA-binding protein HuR in cancer progression, treatment responses and prognosis.

Authors:  Jun Wang; Yan Guo; Huili Chu; Yaping Guan; Jingwang Bi; Baocheng Wang
Journal:  Int J Mol Sci       Date:  2013-05-10       Impact factor: 5.923

Review 7.  Keratinocyte Differentiation-Dependent Human Papillomavirus Gene Regulation.

Authors:  Sheila V Graham
Journal:  Viruses       Date:  2017-08-30       Impact factor: 5.048

Review 8.  Role of the DNA Damage Response in Human Papillomavirus RNA Splicing and Polyadenylation.

Authors:  Kersti Nilsson; Chengjun Wu; Stefan Schwartz
Journal:  Int J Mol Sci       Date:  2018-06-12       Impact factor: 5.923

Review 9.  Role of Viral Ribonucleoproteins in Human Papillomavirus Type 16 Gene Expression.

Authors:  Naoko Kajitani; Stefan Schwartz
Journal:  Viruses       Date:  2020-09-30       Impact factor: 5.048

Review 10.  Strength in Diversity: Nuclear Export of Viral RNAs.

Authors:  Jón Pol Gales; Julie Kubina; Angèle Geldreich; Maria Dimitrova
Journal:  Viruses       Date:  2020-09-11       Impact factor: 5.048

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.